A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...] …
Category: Regulatory
Sanofi is requiring Arkansas hospitals to prove they legally own 340B-priced drugs until they are dispensed at contract pharmacies after [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators last Friday finalized a highly anticipated rule for the Medicaid Drug Rebate Program (MDRP) with new identifiers and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Biden administration deserves credit for playing a key role in passing the first law in history to allow the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal government’s recent threat to penalize Johnson & Johnson (J&J) for its unapproved 340B rebate model could spark a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district judge ruled that four drugmakers’ 340B contract pharmacy restrictions—as implemented in 2021—do not violate the 340B statute, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal agency that oversees the 340B program today formally warned Johnson & Johnson (J&J) that it must “cease implementation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...] …